The Gross Law Firm Notifies Shareholders of Verve Therapeutics, Inc. (VERV) of a Class Action Lawsuit and an Upcoming Deadline

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Verve Therapeutics, Inc. regarding a class action lawsuit related to misleading statements and omissions during a specified class period [1][2]. Group 1: Class Action Details - The class period for the lawsuit is from August 9, 2022, to April 1, 2024 [2]. - Allegations include failure to disclose the circumstances under which the Heart-1 Phase 1b clinical trial of VERVE-101 would be halted, overstating the benefits of its lipid nanoparticle delivery system, and making materially false statements about the company's business and prospects [2]. - The deadline for shareholders to register for the class action is October 28, 2024, and there is no cost or obligation to participate [3]. Group 2: Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and fraud [4]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements or omissions [4].